Form 8-K

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

Current Report Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 14, 2004

 

 

SYNBIOTICS CORPORATION

(Exact name of registrant as specified in its charter)

 

Commission file number 0-11303

 

California   95-3737816

(State or other jurisdiction

of incorporation)

  

(I.R.S. Employer

Identification No.)

 

11011 Via Frontera

San Diego, California

   92127
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (858) 451-3771

 

 

 

Item 5.   Other Events

 

On January 14, 2004, we issued a press release announcing that we had received USDA approval for our Witness® HW in-clinic veterinary diagnostic for the detection of heartworm infection in dogs.

 

Item 7.   Financial Statements, Pro Forma Financial Information and Exhibits

 

  a) Financial statements of businesses acquired

 

  Not applicable.

 

  b) Pro forma financial information

 

  Not applicable.

 

  c) Exhibits

 

  99 Press release dated January 14, 2004, entitled “Synbiotics Announces the Availability of Witness® HW”.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

       

SYNBIOTICS CORPORATION

Date: January 16, 2004

      

/s/    Keith A. Butler        

     
       

Keith A. Butler

Vice President – Finance and Chief Financial Officer

 

-1-

EXHIBIT INDEX

 

Exhibit No.
   

Exhibit

99

    Press release dated January 14, 2004, entitled “Synbiotics Announces the Availability of Witness® HW”.